Delivery Order SPE2DB22D1103-SPE2DB25FTLL0

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product Cosentyx (secukinumab). The contract has a ceiling value of $6,101.68 and a period of performance through June 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg medication. The delivery order, valued at $3,465.90, is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a ceiling value of $3,406.81 and an ultimate completion date of July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,585,932 units of Cosentyx (secukinumab), a specialty medication. The delivery order, valued at $7,609.75, has a firm fixed price and no set-aside designation. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cosentyx (secukinumab) 300 mg doses, a medication used to treat various autoimmune conditions. The contract has a ceiling value of $5,083.65 and a period of performance through April 23, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen holds a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Cosentyx (Secukinumab) 300mg dose. The contract has a ceiling value of $10,528.63 and a period of performance through April 30, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a $5,674.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx, a specialty medication. The contract has an ultimate completion date of July 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract is for the supply of Cosentyx (secukinumab) 300 mg doses in pre-filled syringes, with a total ceiling value of $10,049.44 and a completion date of February 10, 2025. The contract is a firm-fixed-price delivery order, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab), a specialty biologic medication, in a 300mg dose. The contract has a firm fixed price of $18,263.40 and an ultimate completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx 300mg dose injections. The award, valued at $3,486.10, is a firm fixed-price contract with a completion date of January 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTLL0
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Cosentyx (secukinumab) in 300mg doses. The contract has a ceiling value of $3,498.26 and a period of performance through April 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not designated as a set-aside.

Generated 7/29/25, 9:58 AM